December 11, 2014
Sawai Pharmaceutical President Mitsuo Sawai Sawai Pharmaceutical President Mitsuo Sawai predicted on December 9 that an authorized generic (AG) of Blopress (candesartan) will lose its momentum after competitor products make their debut this month. AGs launched by originator-backed companies can...read more